Janux Therapeutics Inc (JANX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Janux Therapeutics Inc   (NASDAQ: JANX)

Janux Therapeutics Inc

Officers & Directors


1. David Campbell, Ph.D. - President and Chief Executive Officer and Director: Dr. Campbell has over 20 years of experience in the biotech industry, focusing particularly on oncology drug development.

2. Jay Lichter, Ph.D. - Chairperson of the Board of Directors: Mr. Lichter is a successful entrepreneur and venture capitalist with expertise in the life sciences industry.

3. Ron Barrett, Ph.D. - Director.

4. Sheila Gujrathi, M.D. - Director.

5. Vickie Capps - Director.

6. Alana McNulty - Director.

7. Winston Kung - Director.

8. Jake Simson, Ph.D. - Director.

9. Tighe Reardon - Acting Chief Financial Officer.

10. David Campbell, Ph.D. - President and Chief Executive Officer (Note: This entry is a repeat).,

Janux Therapeutics Inc currently has 109 employees.






JANX Management Effectiveness JANX Revenue per Employee JANX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.